Nanotech’s first big IPO is not happening. Yesterday, Nanosys announced it was withdrawing its initial public offering because of “adverse market conditions.” The plethora of analysts and pundits suddenly expert on the nanotech market (what market, you might wisely ask) are having a heyday on the profound question of the day: what does it all mean for the future of nanotechnology? The answer is nothing has changed: nanotech is still a few years away from having any significant commercial impact. (The more interesting question is why are all these Wall Street types following an industry that doesn’t even really exist yet.) One does have to think that Nanosys (profiled earlier this year in Technology Review) is making a smart move here–one that will let the company focus on developing the science and technology it will need if it is ever to get products out the door.
Five poems about the mind
Work reinvented: Tech will drive the office evolution
As organizations navigate a new world of hybrid work, tech innovation will be crucial for employee connection and collaboration.
I taught myself to lucid dream. You can too.
We still don’t know much about the experience of being aware that you’re dreaming—but a few researchers think it could help us find out more about how the brain works.
Is everything in the world a little bit conscious?
The idea that consciousness is widespread is attractive to many for intellectual and, perhaps, also emotional
reasons. But can it be tested? Surprisingly, perhaps it can.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.